|
|
|
Volumn 11, Issue 9 SUPPL. 10, 1997, Pages 119-123
|
|
Oral UFT and leucovorin in patients with advanced gastric carcinoma
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CISPLATIN;
DOXORUBICIN;
ETOPOSIDE;
FLUOROURACIL;
FOLINIC ACID;
MITOMYCIN C;
PIRARUBICIN;
UFT;
ANTIDOTE;
ANTINEOPLASTIC AGENT;
TEGAFUR;
UFT(R) DRUG;
URACIL;
ADULT;
AGED;
ALOPECIA;
ANTINEOPLASTIC ACTIVITY;
BLOOD TOXICITY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG EFFICACY;
DRUG POTENTIATION;
FEMALE;
GASTROINTESTINAL TOXICITY;
HUMAN;
MALE;
MUCOSA INFLAMMATION;
ORAL DRUG ADMINISTRATION;
PHASE 2 CLINICAL TRIAL;
STOMACH CARCINOMA;
TREATMENT PLANNING;
ARTICLE;
CARCINOMA;
CHEMICALLY INDUCED DISORDER;
DIARRHEA;
DRUG COMBINATION;
FOLLOW UP;
LEUKOPENIA;
MIDDLE AGED;
MORTALITY;
NAUSEA;
STOMACH TUMOR;
SURVIVAL RATE;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTIDOTES;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA;
DIARRHEA;
DRUG COMBINATIONS;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
LEUCOVORIN;
LEUKOPENIA;
MALE;
MIDDLE AGED;
NAUSEA;
STOMACH NEOPLASMS;
SURVIVAL RATE;
TEGAFUR;
TREATMENT OUTCOME;
URACIL;
|
|
EID: 0031228043
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (20)
|
|
References (5)
|
